772
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cubosomal Betamethasone-Salicylic Acid Nano Drug Delivery System for Enhanced Management of Scalp Psoriasis

, & ORCID Icon
Pages 1659-1677 | Published online: 13 Apr 2022

References

  • Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. doi:10.3390/ijms20061475
  • Papp K, Berth‐Jones J, Kragballe K, Wozel G, De La Brassinne M. Scalp psoriasis: a review of current topical treatment options. J Eur Acad Dermatol Venereol. 2007;21:151–160.
  • Chan CS, Van Voorhees AS, Lebwohl MG, et al. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;60(6):962–971. doi:10.1016/j.jaad.2008.11.890
  • El-Komy MH, Mashaly H, Sayed KS, et al. Clinical and epidemiologic features of psoriasis patients in an Egyptian medical center. JAAD Int. 2021;1:81–90.
  • EBSCOhost. 128564902 | Scalp psoriasis: management and treatment. 2021.
  • van de Kerkhof PCM, de Hoop D, de Korte J, Kuipers MV. Scalp psoriasis, clinical presentations and therapeutic management. Dermatology. 1998;197(4):326–334. doi:10.1159/000018026
  • Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–1960. doi:10.1001/jama.2020.4006
  • Le Roux E, Frow H. Diagnosis and management of mild to moderate psoriasis. Prescriber. 2021;31(7–8):9–17. doi:10.1002/psb.1855
  • Dhar S, Seth J, Parikh D. Systemic side-effects of topical corticosteroids. Indian J Dermatol. 2014;59(5):460–464. doi:10.4103/0019-5154.139874
  • Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: a long overdue revisit. Indian Dermatol Online J. 2014;5(4):416–425. doi:10.4103/2229-5178.142483
  • Del Rosso JQ. Ceramide- and keratolytic-containing body cleanser and cream application in patients with psoriasis: outcomes from a consumer usage study. J Clin Aesthetic Dermatol. 2019;12(7):18–21.
  • Torsekar R, Gautam MM. Topical therapies in psoriasis. Indian Dermatol Online J. 2017;8(4):235. doi:10.4103/2229-5178.209622
  • Kravvas G, Gholam K. Use of topical therapies for pediatric psoriasis: a systematic review. Pediatr Dermatol. 2018;35(3):296–302. doi:10.1111/pde.13422
  • van de Kerkhof PCM, Vissers WH. The topical treatment of psoriasis. Skin Pharmacol Physiol. 2003;16(2):69–83. doi:10.1159/000069029
  • Gaballa SA, El Garhy OH, Abdelkader H. Cubosomes: composition, preparation, and drug delivery applications. J Adv Biomed Pharm Sci. 2020;3(1):1–9.
  • Patel D, Patel B, Thakkar H. Lipid based nanocarriers: promising drug delivery system for topical application. Eur J Lipid Sci Technol. 2021;123(5):2000264. doi:10.1002/ejlt.202000264
  • Garg G, Saraf S, Saraf S. Cubosomes: an overview. Biol Pharm Bull. 2007;30(2):350–353. doi:10.1248/bpb.30.350
  • Dhadwal A, Sharma DR, Pandit V, Ashawat MS, Kumar P. Cubosomes: a novel carrier for transdermal drug delivery. J Drug Deliv Ther. 2020;10(1):123–130. doi:10.22270/jddt.v10i1.3814
  • Hameed A, Fatima GR, Malik K, Muqadas A, Fazal-ur-Rehman M. Scope of nanotechnology in cosmetics: dermatology and skin care products. J Med Chem Sci. 2019;2(1):9–16.
  • Rahman MS, Hasan MS, Nitai AS, et al. Recent developments of carboxymethyl cellulose. Polymers. 2021;13(8):1345. doi:10.3390/polym13081345
  • SpringerLink. Viscosity properties of sodium carboxymethylcellulose solutions. 2021.
  • Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive delivery systems. I. evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm. 2004;30(9):985–993. doi:10.1081/DDC-200037245
  • Esposito E, Eblovi N, Rasi S, et al. Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSci. 2003;5(4):62–76. doi:10.1208/ps050430
  • SpringerLink. Cubosomes: structure, preparation and use as an antigen delivery system. 2021.
  • Morsi NM, Abdelbary GA, Ahmed MA. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm. 2014;86(2):178–189. doi:10.1016/j.ejpb.2013.04.018
  • Gad HA, El-Nabarawi MA, Abd El-Hady SS. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis. AAPS PharmSciTech. 2008;9(3):878. doi:10.1208/s12249-008-9126-9
  • Barnes HA, Hutton JF, Walters K. An Introduction to Rheology. Elsevier; 1989.
  • Khan M, Sardar H, Gulzar MM, Alshomrani AS. On multiple solutions of non-Newtonian Carreau fluid flow over an inclined shrinking sheet. Results Phys. 2018;8:926–932. doi:10.1016/j.rinp.2018.01.021
  • PerkinElmer. HPLC analysis of betamethasone dipropionate using a Quasar C18 column in accordance with the United States pharmacopeia. Available from: https://www.perkinelmer.com/libraries/ABR_HPLC-Analysis-of-BetamethasoneDipropionateUsing-a-QuasarC18Column. Accessed August 15, 2021.
  • Jani DH, Patel SA. Spectrophotometric determination of salicylic acid from single as well as combined dosage form. J Pharmaceutical Res. 2021;7:938–947.
  • Farag MM, Abd El Malak NS, Yehia SA, Ahmed MA. Sonocomplexation as an effective tool to enhance the antitumorigenic effect of metformin: preparation, in vitro characterization, molecular dynamic simulation & MiaPaCa-2 cell line hypoxia evaluation. J Drug Deliv Sci Technol. 2020;59:101968. doi:10.1016/j.jddst.2020.101968
  • Simon A, de Almeida Borges VR, Cabral LM, de Sousa VP. Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension. AAPS PharmSciTech. 2013;14(1):425–434. doi:10.1208/s12249-012-9920-2
  • Albus U. Guide for the care and use of laboratory animals (8th edn). Lab Anim. 2012;46(3):267–268. doi:10.1258/la.2012.150312
  • Agrawal YO, Mahajan UB, Mahajan HS, Ojha S. Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: formulation, optimization, characterization, in-vitro and in-vivo studies. Int J Nanomedicine. 2020;15:4763–4778. doi:10.2147/IJN.S247007
  • Satake K, Amano T, Okamoto T. Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis. Eur J Pharmacol. 2018;826:31–38. doi:10.1016/j.ejphar.2018.02.032
  • Mori H, Arita K, Yamaguchi T, Hirai M, Kurebayashi Y. Effects of topical application of betamethasone on imiquimod-induced psoriasis-like skin inflammation in mice. Kobe J Med Sci. 2016;62(4):E79–E88.
  • Harari M, Shani J, Hristakieva E, Stanimirovic A, Seidl W, Burdo A. Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the dead‐sea. Int J Dermatol. 2022;39:913–918.
  • Avasatthi V, Pawar H, Dora CP, Bansod P, Gill MS, Suresh S. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol. 2016;21(5):554–562. doi:10.3109/10837450.2015.1026605
  • Meng S, Sun L, Wang L, et al. Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity. Colloids Surf B Biointerfaces. 2019;182:110352. doi:10.1016/j.colsurfb.2019.110352
  • Culling CFA. Handbook of Histopathological and Histochemical Techniques: Including Museum Techniques. Butterworth-Heinemann; 2013.
  • Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57. doi:10.3390/Pharmaceutics10020057
  • Bera B. Nanoporous silicon prepared by vapour phase strain etch and sacrificial technique. Int J Comput Appl. 2021;975:8887.
  • Clogston JD, Patri AK. Zeta potential measurement. In: McNeil SE, editor. Characterization of Nanoparticles Intended for Drug Delivery. Methods in Molecular Biology. Humana Press; 2011:63–70.
  • Rizwan SB, Hanley T, Boyd BJ, Rades T, Hook S. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci. 2009;98(11):4191–4204. doi:10.1002/jps.21724
  • ScienceDirect. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. 2021.
  • Thatipamula RP, Palem CR, Gannu R, Mudragada S, Yamsani MR. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. DARU J Fac Pharm Tehran Univ Med Sci. 2011;19(1):23–32.
  • Oun AA, Rhim JW. Preparation and characterization of sodium carboxymethyl cellulose/cotton linter cellulose nanofibril composite films. Carbohydr Polym. 2015;127:101–109. doi:10.1016/j.carbpol.2015.03.073
  • SpringerLink. Rheological investigation of body cream and body lotion in actual application conditions. 2021.
  • Bird RB, Dai GC, Yarusso BJ. The rheology and flow of viscoplastic materials. Rev Chem Eng. 1983;1(1):1–70. doi:10.1515/revce-1983-0102
  • Waqas M, Khan MI, Hayat T, Alsaedi A. Numerical simulation for magneto Carreau nanofluid model with thermal radiation: a revised model. Comput Methods Appl Mech Eng. 2017;324:640–653. doi:10.1016/j.cma.2017.06.012
  • Al-sakini S, Maraie N. Optimization and in vitro evaluation of the release of class ii drug from its nanocubosomal dispersion. Int J Appl Pharm. 2019;11:86–90. doi:10.22159/ijap.2019v11i2.30582
  • Sayed S, Abdel-Moteleb M, Amin MM, Khowessah OM. Cubogel as potential platform for glaucoma management. Drug Deliv. 2021;28(1):293–305. doi:10.1080/10717544.2021.1872740
  • Mealey D, Croker DM, Rasmuson ÅC. Crystal nucleation of salicylic acid in organic solvents. Cryst Eng Comm. 2015;17(21):3961–3973. doi:10.1039/C4CE01428F
  • Bhosale R, Osmani R, Harkare B, Ghodake P. Cubosomes: the inimitable nanoparticulate drug carriers. Sch Acad J Pharm. 2013;2:481–486.
  • El Malki K, Karbach SH, Huppert J, et al. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor A signaling. J Invest Dermatol. 2013;133(2):441–451. doi:10.1038/jid.2012.318
  • Na Takuathung M, Wongnoppavich A, Panthong A, et al. Antipsoriatic effects of wannachawee recipe on imiquimod-induced psoriasis-like dermatitis in BALB/c mice. ECAM. 2018;2018:7931031. doi:10.1155/2018/7931031
  • Fredriksson T, Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatology. 1978;157(4):238–244. doi:10.1159/000250839
  • Liu F, Wang S, Liu B, Wang Y, Tan W. (R)-salbutamol improves imiquimod-induced psoriasis-like skin dermatitis by regulating the Th17/Tregs balance and glycerophospholipid metabolism. Cells. 2022;9:511. doi:10.3390/cells9020511
  • Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45(3):264–272. doi:10.1111/1346-8138.14139